Literature DB >> 17884970

Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis.

Tatsuo Hashimoto1, Minoru Kihara, Nozomi Imai, Shin-Ichiro Yoshida, Hiroaki Shimoyamada, Hiroaki Yasuzaki, Junji Ishida, Yoshiyuki Toya, Yoshihiro Kiuchi, Nobuhito Hirawa, Kouichi Tamura, Takuya Yazawa, Hitoshi Kitamura, Akiyoshi Fukamizu, Satoshi Umemura.   

Abstract

The recently identified endogenous peptide apelin and its specific apelin receptor (APJ) are currently being considered as potential regulators in vascular tissue. Previously, we reported apelin mediates phosphorylation of myosin light chain and elicits vasoconstriction in vascular smooth muscle. In this study, physiological roles of the apelin-APJ system were investigated on atherosclerosis. In APJ and apolipoprotein E double-knockout (APJ(-/-)ApoE(-/-)) mice fed a high-cholesterol diet, atherosclerotic lesions were dramatically reduced when compared with APJ(+/+) ApoE(-/-) mice, in the absence of an effect of cholesterol levels. Immunohistochemical detection of smooth muscle cells, using a smooth muscle alpha-actin antibody, showed greatly reduced staining for these cells in lesions of APJ(-/-)ApoE(-/-) mice fed a high-cholesterol diet. Vascular production of superoxide radicals and the expression of nicotinamide-adenine dinucleotide phosphate oxidase subunits were decreased in APJ(-/-)ApoE(-/-) mice compared with APJ(+/+)ApoE(-/-) mice fed a standard normal diet. In vascular smooth muscle cells, apelin induced nicotinamide-adenine dinucleotide phosphate oxidase subunit expression. Apelin also induced vascular smooth muscle cell proliferation, which was inhibited by superoxide dismutase or diphenylene iodonium. The apelin-APJ system is a mediator of oxidative stress in vascular tissue, and thus we propose it to be a critical factor in atherogenesis under high-cholesterol dietary conditions. APJ deficiency is preventative against oxidative stress-linked atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884970      PMCID: PMC2043530          DOI: 10.2353/ajpath.2007.070471

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin.

Authors:  J B Laursen; M Somers; S Kurz; L McCann; A Warnholtz; B A Freeman; M Tarpey; T Fukai; D G Harrison
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

2.  Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.

Authors:  Masaru Iwai; Rui Chen; Zhen Li; Tetsuya Shiuchi; Jun Suzuki; Ayumi Ide; Masahiro Tsuda; Midori Okumura; Li-Juan Min; Masaki Mogi; Masatsugu Horiuchi
Journal:  Circulation       Date:  2005-09-06       Impact factor: 29.690

3.  Angiotensinergic stimulation of vascular endothelium in mice causes hypotension, bradycardia, and attenuated angiotensin response.

Authors:  Ramaswamy Ramchandran; Takanobu Takezako; Yasser Saad; Linda Stull; Bruno Fink; Hirotsugu Yamada; Sergey Dikalov; David G Harrison; Christine Moravec; Sadashiva S Karnik
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-05       Impact factor: 11.205

4.  A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11.

Authors:  B F O'Dowd; M Heiber; A Chan; H H Heng; L C Tsui; J L Kennedy; X Shi; A Petronis; S R George; T Nguyen
Journal:  Gene       Date:  1993-12-22       Impact factor: 3.688

5.  Effects of all-trans retinoic acid on orphan receptor APJ signaling in spontaneously hypertensive rats.

Authors:  Jiu-Chang Zhong; Dong-Yang Huang; Ge-Fei Liu; Hai-Yan Jin; Yan-Mei Yang; Yi-Fan Li; Xu-Hong Song; Kun Du
Journal:  Cardiovasc Res       Date:  2005-02-15       Impact factor: 10.787

6.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

7.  Heparin recovers AT1 receptor and its intracellular signal transduction in cultured vascular smooth muscle cells.

Authors:  Tatsuo Hashimoto; Minoru Kihara; Keiko Sato; Nozomi Imai; Yutaka Tanaka; Masashi Sakai; Kouichi Tamura; Nobuhito Hirawa; Yoshiyuki Toya; Hitoshi Kitamura; Satoshi Umemura
Journal:  FEBS Lett       Date:  2005-01-03       Impact factor: 4.124

8.  Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.

Authors:  K Tatemoto; M Hosoya; Y Habata; R Fujii; T Kakegawa; M X Zou; Y Kawamata; S Fukusumi; S Hinuma; C Kitada; T Kurokawa; H Onda; M Fujino
Journal:  Biochem Biophys Res Commun       Date:  1998-10-20       Impact factor: 3.575

9.  Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.

Authors:  Sven Wassmann; Thomas Czech; Martin van Eickels; Ingrid Fleming; Michael Böhm; Georg Nickenig
Journal:  Circulation       Date:  2004-07-26       Impact factor: 29.690

Review 10.  Using mice to dissect genetic factors in atherosclerosis.

Authors:  Hooman Allayee; Anatole Ghazalpour; Aldons J Lusis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-08-14       Impact factor: 8.311

View more
  38 in total

1.  Modulation of the apelin/APJ system in heart failure and atherosclerosis in man.

Authors:  Sarah L Pitkin; Janet J Maguire; Rhoda E Kuc; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Upregulation of the apelin-APJ pathway promotes neointima formation in the carotid ligation model in mouse.

Authors:  Yoko Kojima; Ramendra K Kundu; Christopher M Cox; Nicholas J Leeper; Joshua A Anderson; Hyung J Chun; Ziad A Ali; Euan A Ashley; Paul A Krieg; Thomas Quertermous
Journal:  Cardiovasc Res       Date:  2010-02-22       Impact factor: 10.787

Review 3.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

4.  Pressor effect of apelin-13 in the rostral ventrolateral medulla: role of NAD(P)H oxidase-derived superoxide.

Authors:  Fanrong Yao; Amit Modgil; Qi Zhang; Ajeeth Pingili; Neha Singh; Stephen T O'Rourke; Chengwen Sun
Journal:  J Pharmacol Exp Ther       Date:  2010-11-03       Impact factor: 4.030

5.  Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin.

Authors:  Sophie Le Gonidec; Carline Chaves-Almagro; Yushi Bai; Hye Jin Kang; Allyson Smith; Estelle Wanecq; Xi-Ping Huang; Hervé Prats; Bernard Knibiehler; Bryan L Roth; Larry S Barak; Marc G Caron; Philippe Valet; Yves Audigier; Bernard Masri
Journal:  FASEB J       Date:  2017-02-27       Impact factor: 5.191

Review 6.  The Role of Adipocytokines in Coronary Atherosclerosis.

Authors:  Luca Liberale; Aldo Bonaventura; Alessandra Vecchiè; Matteo Casula; Franco Dallegri; Fabrizio Montecucco; Federico Carbone
Journal:  Curr Atheroscler Rep       Date:  2017-02       Impact factor: 5.113

Review 7.  Genetic basis of atherosclerosis: insights from mice and humans.

Authors:  Ioannis M Stylianou; Robert C Bauer; Muredach P Reilly; Daniel J Rader
Journal:  Circ Res       Date:  2012-01-20       Impact factor: 17.367

Review 8.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

9.  Mechanisms by which diabetes increases cardiovascular disease.

Authors:  Christian A Gleissner; Elena Galkina; Jerry L Nadler; Klaus Ley
Journal:  Drug Discov Today Dis Mech       Date:  2007

10.  Endogenous regulation of cardiovascular function by apelin-APJ.

Authors:  David N Charo; Michael Ho; Giovanni Fajardo; Masataka Kawana; Ramendra K Kundu; Ahmad Y Sheikh; Thomas P Finsterbach; Nicholas J Leeper; Kavita V Ernst; Mary M Chen; Yen Dong Ho; Hyung J Chun; Daniel Bernstein; Euan A Ashley; Thomas Quertermous
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-18       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.